Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid-thrombosis interface

K A Mitropoulos1

  • 1MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, Medical College, St Bartholomew's Hospital, London, UK.

British Medical Bulletin
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.

Thrombosis and haemostasis·1999
Same author

High affinity binding of factor XIIa to an electronegative surface controls the rates of factor XII and prekallikrein activation in vitro.

Thrombosis research·1999
Same author

Very low activated factor VII and reduced factor VII antigen in familial abetalipoproteinaemia.

Thrombosis and haemostasis·1998
Same author

Influence of n-6 versus n-3 polyunsaturated fatty acids in diets low in saturated fatty acids on plasma lipoproteins and hemostatic factors.

Arteriosclerosis, thrombosis, and vascular biology·1998
Same author

Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group.

European heart journal·1997
Same author

Activation of acyl-CoA: cholesterol acyltransferase in rat liver microsomes by 25-hydroxycholesterol.

Biochemical pharmacology·1997

Remnants from triglyceride-rich lipoproteins activate coagulation, potentially increasing thrombus formation and inflammation. This highlights the link between lipid metabolism, coagulation, and cardiovascular disease risk.

Area of Science:

  • Biochemistry
  • Vascular Biology
  • Cardiovascular Medicine

Background:

  • Lipolysis of triglyceride-rich lipoproteins generates remnants that activate the coagulation contact system.
  • Activated factor VII (VIIa) may initiate rapid thrombin generation at atheromatous lesions or injury sites.
  • Vascular homeostasis relies on balanced coagulation and fibrinolytic systems, with imbalances increasing thrombosis or bleeding risks.

Purpose of the Study:

  • To review evidence on the role of remnant lipoproteins in coagulation activation.
  • To discuss the significance of increased circulating activated factor VII (VIIa) in thrombus propagation and inflammatory responses.
  • To examine the role of PAI-1 in fibrinolysis regulation and its link to hypertriglyceridemia.
  • To explore the association between lipoprotein (a) and coronary heart disease via plasminogen activation interference.

Related Experiment Videos

Main Methods:

  • Literature review of existing evidence.
  • Analysis of the biochemical pathways involved in lipoprotein metabolism and coagulation.
  • Examination of the regulatory roles of PAI-1 and lipoprotein (a) in vascular homeostasis.

Main Results:

  • Remnant lipoproteins activate coagulation factor VII, leading to thrombin generation.
  • Elevated VIIa levels accelerate thrombin production at sites of vascular damage.
  • PAI-1 activity is linked to hypertriglyceridemia, affecting fibrinolysis.
  • Lipoprotein (a) interferes with plasminogen activation, contributing to coronary heart disease.

Conclusions:

  • Lipoprotein remnants play a critical role in initiating coagulation and thrombin formation.
  • Imbalances in coagulation and fibrinolysis, influenced by lipid profiles, significantly impact cardiovascular health.
  • Understanding these interactions is crucial for managing thrombosis and related inflammatory responses.